Synovus Financial’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-290
Closed -$8K 747
2020
Q2
$8K Sell
290
-1
-0.3% -$29 ﹤0.01% 1239
2020
Q1
$7K Sell
291
-64
-18% -$1.91K ﹤0.01% 1671
2019
Q4
$12K Sell
355
-103
-22% -$3.73K ﹤0.01% 1179
2019
Q3
$15K Sell
458
-52
-10% -$1.98K ﹤0.01% 1126
2019
Q2
$19K Hold
510
﹤0.01% 1029
2019
Q1
$19K Sell
510
-22,314
-98% -$999K ﹤0.01% 1017
2018
Q4
$1.02M Sell
22,824
-9,130
-29% -$478K 0.02% 296
2018
Q3
$2.19M Sell
31,954
-5,566
-15% -$358K 0.03% 213
2018
Q2
$2.15M Buy
37,520
+14
+0% +$740 0.04% 215
2018
Q1
$1.73M Buy
37,506
+1,988
+6% +$94.4K 0.03% 236
2017
Q4
$1.64M Buy
+35,518
New +$1.63M 0.03% 231
2017
Q2
Sell
-3,229
Closed -$122K 797
2017
Q1
$122K Buy
3,229
+5
+0.2% +$195 ﹤0.01% 598
2016
Q4
$117K Sell
3,224
-100
-3% -$3.57K ﹤0.01% 590
2016
Q3
$113K Sell
3,324
-472
-12% -$16.5K ﹤0.01% 589
2016
Q2
$122K Hold
3,796
﹤0.01% 547
2016
Q1
$108K Hold
3,796
﹤0.01% 563
2015
Q4
$125K Sell
3,796
-358
-9% -$11.1K ﹤0.01% 509
2015
Q3
$117K Sell
4,154
-864
-17% -$30.1K ﹤0.01% 480
2015
Q2
$202K Sell
5,018
-1,019
-17% -$45.7K 0.01% 423
2015
Q1
$298K Sell
6,037
-1,474
-20% -$68.3K 0.01% 405
2014
Q4
$347K Buy
+7,511
New +$295K 0.01% 388

Other funds holding AVNS

Synovus Financial's AVNS Position: Q3 2020 in Review

Synovus Financial sold out of Avanos Medical (AVNS) in Q3 2020, closing a stake of 290 shares — an estimated $8K sold.

Synovus Financial first reported a position in AVNS in Q4 2014 and held it in 21 quarters. The position peaked at $2.19M in Q3 2018. 272 funds tracked by Wall St. Rank hold AVNS as of Q3 2020.

  • Synovus Financial reported no remaining Avanos Medical position as of Q3 2020 after selling out during the quarter.
  • Synovus Financial sold 290 Avanos Medical shares in Q3 2020, an estimated $8K.
  • Synovus Financial first reported a position in Avanos Medical in Q4 2014 and held it in 21 quarters.
  • Synovus Financial's Avanos Medical position peaked at $2.19M in Q3 2018.
  • 272 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2020.

Based on Synovus Financial's 13F filing for Q3 2020, filed 9 Nov 2020.